Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.07.24	Pfizer Advances Once-Daily Weight-Loss Pill As It Catches Up To Tap The Lucrative Market (Benzinga)
11.07.24	Pfizer signals progress on obesity pill, boosting stock (MarketWatch)
11.07.24	Pfizer pins hopes on daily pill to crack market for weight-loss drugs (Financial Times)
11.07.24	Pfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist Danuglipron (Businesswire)
10.07.24	Pfizer And Mainz Provide Examples Of Using Emerging Technology For Good (Benzinga)
09.07.24	Pfizer Launches Process To Identify Chief Scientific Officer Successor (Benzinga)
09.07.24	Pfizer Options Trading: A Deep Dive into Market Sentiment (Benzinga)
09.07.24	Pfizer to Launch Process to Identify a Successor for Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & Development (Businesswire)
08.07.24	Want $1,000 in Dividend Income? Here's How Much You Have to Invest in Pfizer Stock (MotleyFool)
08.07.24	Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip? (MotleyFool)
03.07.24	What the Options Market Tells Us About Pfizer (Benzinga)
02.07.24	London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents (Benzinga)
01.07.24	A Glimpse Into The Expert Outlook On Pfizer Through 9 Analysts (Benzinga)
01.07.24	Cyrus Taraporevala Elected to Pfizer’s Board of Directors (Businesswire)
28.06.24	This Is What Whales Are Betting On Pfizer (Benzinga)
28.06.24	Is Pfizer Stock a Buy? (MotleyFool)
27.06.24	This Recent FDA Approval Is Bad News for Pfizer (MotleyFool)
27.06.24	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union (RSS)
27.06.24	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union (Businesswire)
26.06.24	Pfizer Declares Third-Quarter 2024 Dividend (Businesswire)
26.06.24	What's Going On With Pfizer Shares Wednesday? (Benzinga)
24.06.24	UK Chooses Pfizer Over GSK for Multi-Million Dose RSV Vaccine Contract (Benzinga)
24.06.24	Alnylam’s stock surges as heart drug vies with a Pfizer blockbuster (MarketWatch)
19.06.24	Palantir, Oracle, Pfizer Chiefs Lobby US Lawmakers For Israel's Support Amid Hamas Attack, Hostage Crisis (Benzinga)
18.06.24	Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb (MotleyFool)
18.06.24	Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts (Businesswire)
18.06.24	Kansas sues Pfizer, saying it misled the public over COVID-19 vaccine (MarketWatch)
17.06.24	Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday? (Benzinga)
14.06.24	Is It Too Late to Buy Pfizer Stock? (MotleyFool)
14.06.24	ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma (Businesswire)
13.06.24	What's Going On With Pfizer On Thursday? Pharma Giant's Shares Tick Lower (Benzinga)
12.06.24	Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy (Businesswire)
10.06.24	Spotlight on Pfizer: Analyzing the Surge in Options Activity (Benzinga)
05.06.24	Why Things Could Get Worse for Pfizer Stock Before They Get Better (MotleyFool)
03.06.24	Pfizer Unusual Options Activity For June 03 (Benzinga)
03.06.24	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
01.06.24	Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/?Refractory Diffuse Large B-cell Lymphoma (DLBCL) (Businesswire)
01.06.24	Is Pfizer the Best Dividend Stock for You? (MotleyFool)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	551.60	5.59 %	K V
CieFinRichemont	134.80	0.86 %	K V
UBS Group	28.51	0.74 %	K V
Holcim	89.88	0.74 %	K V
ABB	52.00	0.12 %	K V
Swiss Life Hldg	687.80	-0.58 %	K V
Givaudan	4’015.00	-0.62 %	K V
Sika	230.40	-0.69 %	K V
Roche Hldg G	253.60	-0.90 %	K V
Kuehne+Nagel Int	203.70	-3.41 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Pfizer Inc Cert.Deposito Arg.Repr. 0.5 Shs

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten